Related Experiment Video
Updated: Feb 26, 2026

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
A Computational Method for Unveiling the Target Promiscuity of Pharmacologically Active Compounds
Petra Schneider1, Gisbert Schneider2,1
1inSili.com LLC, Segantinisteig 3, 8049, Zurich, Switzerland.
A new computational method identifies previously unknown drug targets. This approach aids in designing safer, more effective medicines by considering multitarget drug activity, advancing drug discovery and repurposing.
Area of Science:
- Computational chemistry
- Pharmacology
- Machine learning
Background:
- Drug discovery traditionally seeks selective ligands, but many drugs interact with multiple macromolecular targets.
- Understanding polypharmacology is crucial for designing future medicines and avoiding off-target effects.
Purpose of the Study:
- To present a straightforward computational method for identifying novel targets of known drugs.
- To validate the method's efficacy in discovering previously unknown targets for specific compounds.
Main Methods:
- Development of a computational model to predict drug-target interactions.
- Application of the model to analyze known compounds, including resveratrol and celecoxib.
- Experimental validation of predicted novel targets.
Main Results:
- The computational method successfully identified previously unknown macromolecular targets for resveratrol and celecoxib.
- Validation experiments confirmed these novel drug-target interactions.
- Demonstrated the utility of machine learning in uncovering polypharmacology.
Conclusions:
- The developed computational method is effective for discovering new drug targets.
- Machine learning facilitates polypharmacology-based drug design and drug repurposing.
- The approach aids in understanding and assigning phenotypic drug effects to specific targets.
More Related Videos
Related Concept Videos
Drug Discovery: Overview
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Pharmacogenomics: Identification of New Drug Targets
Protein-Drug Binding: Determination Methods
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Quantitative Aspects of Drug-Receptor Interaction

